Towards the elimination of onchocerciasis

REFERENCES

• Abiose, A. (1998). Onchocercal eye disease and the impact of Mectizan treatment. Annals of Tropical Medicine and Parasitology, 92 (Suppl. 1), S11—S22.
   Google Scholar
• Alley, E. S., Plaisier, A. P., Boatin, B. A., Dadzie, K. Y., Remme, J., Zerbo, G. & Samba, E. M. (1994). The impact of five years of annual ivermectin treatment on skin microfilarial loads in the onchocerciasis focus of Asubende, Ghana. Transactions of the Royal Society of Tropical Medicine and Hygiene, 88, 581–584.
   PubMed Web of Science ®Google Scholar
• Amazigo, U. V., Brieger, W. R., Katabarwa, M., Akogun, O., Ntep, M., Boatin, B., N'Doyo, J., Noma, M. & Sékétéli, A. (2002a). The challenges of community-directed treatment with ivermectin (CDTI) within the African Programme of Onchocerciasis Control (APOC). Annals of Tropical Medicine and Parasitology, 96 (Suppl. 1), S41—S58.
   Google Scholar
• Amazigo, U. V., Obono, D. M., Dadzie, K. Y., Remme, J., Jiya, J., Ndyomugyenyi, R., Roungou, J. B., Noma, M. & Sékétéli, A. (2002b). Monitoring community-directed treatment pro-grammes for sustainability: lessons from the African Programme for Onchocerciasis control. Annals of Tropical Medicine and Parasitology, 96 (Suppl. 1), S75–S92.
   Google Scholar
• Anderson, J., Fuglsang, H., Hamilton, P. J. S. & Marshall, T. F. de C. (1974). Studies on onchocer-ciasis in the United Cameroon Republic. II. Comparison of onchocerciasis in rain-forest and Sudan savanna. Transactions of the Royal Society of Tropical Medicine and Hygiene, 68, 209-222.
   Google Scholar
• Anon. (2004). Recommendations for the Treatment of Onchocerciasis with Mectizan® in Areas Co-endemic for Onchocerciasis and Loiasis. Decatur, GA: Mectizan Donation Program.
   Google Scholar
• Anon. (2005). Eleventh Session of the Joint Action Forum. Ouagadougou: African Programme for Onchocerciasis Control.
   Google Scholar
• Awadzi, K., Dadzie, K. Y., Schulz-Key, H., Haddock, D. R. W., Gilles, H. M. & Aziz, M. A. (1985). The chemotherapy of onchocerciasis. X. An assessment of four single dose treatments regimes of MK-933 (ivermectin) in human onchocerciasis. Annals of Tropical Medicine and Parasitology, 79, 63-78.
   Google Scholar
• Awadzi, K., Dadzie, K. Y., Schulz-Key, H., Gilles, H. M., Fulford, A. J. & Aziz, M. A. (1986). The chemotherapy of onchocerciasis. XI. A double-blind comparative study of ivermectin, diethylcarbamazine and placebo in human onchocerciasis in Northern Ghana. Annals of Tropical Medicine and Parasitology, 80, 433-442.
   Google Scholar
• Awadzi, K., Boakye, D. A., Edwards, G., Opoku, N. O., Attah, S. K., Osei-Atweneboana, M. Y., Lazdins-Helds, J. K., Ardrey, A. E., Addy, E. T., Quartey, B. T., Ahmed, K., Boatin, B. A. & Soumbey-Alley, E. W. (2004). An investigation of persistent micro-filaridermias despite multiple treatments with iver-mectin in two onchocerciasis-endemic foci of Ghana. Annals of Tropical Medicine and Parasitology, 98, 231-249.
   Google Scholar
• Bird, A. C., El Sheikh, H., Anderson, J. & Fuglsang, H. (1980). Changes in visual function and in the posterior segment of the eye during treatment of onchocerciasis with diethylcarbamazine-citrate. British Journal of Ophthalmology, 64, 191-200.
   Google Scholar
• Boatin, B., Moyneux, J. M., Hougard, J. M., Christensen, O. W., Alley, E. S., Yaméogo, L., Sékétéli, A. & Dadzie, K. Y. (1997). Patterns of epidemiology and control of onchocerciasis in West Africa. Journal of Helminthology, 71,91-101.
   Google Scholar
• Boatin, B. A., Toé, L., Alley, E. S., Dembélé, N., Wies, N. & Dadzie, K. Y. (1998). Diagnostics in onchocerciasis: future challenges. Annals of Tropical Medicine and Parasitology, 92 (Suppl. 1), 541–S45.
   Google Scholar
• Borsboom, G. J. J. M., Boatin, B. A., Nagelkerke, N. J. D., Agoua, H., Akpoboua, K. L. B., Alley, E. W. S., Bissan, Y., Renz, A., Yaméogo, L., Remme, J. H. F., & Habbema, J. D. F. (2003). Impacts of ivermectin on onchocerciasis trans-mission: assessing the empirical evidence that repeated ivermectin mass treatments may lead to elimination/eradication in West Africa. Filaria Journal, 2, 8.
   Google Scholar
• Brabin, L. (1990). Factors affecting the differential susceptibility of males and females to onchocerciasis. Acta Leidensia, 59, 413–426.
   PubMedGoogle Scholar
• Burnham, G. & Mebrahtu, T. (2004). The delivery of ivermectin (Mectizan®). Tropical Medicine and International Health, 9 (Suppl.), A26–A44.
   Google Scholar
• Battier, D. W., Laer, G. V., Mannweiler, E. & Battier, M. (1982). Clinical, parasitological and serological studies on onchocerciasis in the Yemen Arab Republic. Tropenmedizin und Parasitologie, 33, 201-212.
   Google Scholar
• Campbell, W. C., Fischer, M. H., Shapley, E. O., Albers-Schonberg, G. & Jacob, T. A. (1983). Ivermectin: a potent new antiparasitic agent. Science, 221, 823-828.
   Google Scholar
• Cupp, E. W., Bernardo, M. J., Kiszewski, A. E., Collins, R. C., Taylor, H. R., Aziz, M. A. & Greene, B. M. (1986). The effects of ivermectin on transmis-sion of Onchocerca volvulus. Science, 231, 740-742.
   Google Scholar
• Cupp, E. W., Ochoa, A. O., Collins, R. C., Ramberg, F. R & Zea, G. (1989). The effect of multiple ivermectin treatments on infection of Simulium ochraceum with Onchocerca volvulus. American Journal of Tropical Medicine and Hygiene, 40, 501-506.
   Google Scholar
• Dadzie, K. Y., Bird, A. C., Awadzi, K., Schulz-Key, H., Gilles, H. M. & Aziz, M. A. (1987). Ocular findings in the double-blind study of ivermectin versus diethylcarbamazine versus placebo in the treatment of onchocerciasis. British Journal of Ophthalmology, 71, 78-85.
   Google Scholar
• Dadzie, K. Y., Awadzi, K., Bird, A. C. & Schulz-Key, H. (1989). Ophthalmological results from a placebo controlled comparative 3-dose ivermectin study in the treatment of onchocerciasis. Tropical Medicine and Parasitology, 40, 355-360.
   Google Scholar
• Dadzie, K. Y., Remme, J. & de Sole, G. (1991). Changes in ocular onchocerciasis after two rounds of community based ivermectin treatment in a holo-endemic onchocerciasis focus. Transactions of the Royal Society of Tropical Medicine and Hygiene, 85, 267–271.
   PubMed Web of Science ®Google Scholar
• Dadzie, Y., Neira, M. & Hopkins, D. (2003). Final Report of the Conference on the Eradicability of Onchocerciasis. Filaria Journal, 2,2.
   PubMedGoogle Scholar
• Drameh, P. S., Richards, F. O., Cross, C., Etyaale, D. E. & Kassalow, J. S. (2002). Ten years of NGDO action against river blindness. Trends in Parasitology, 18, 378-380.
   Google Scholar
• Duke, B. O. L. (2005). Evidence for microfilaricidal activity of ivermectin against female Onchocerca volvulus; further analysis of a clinical trial in the Republic of Cameroon indicating two distinct killing mechanisms. Parasitology, 130, 447-453.
   Google Scholar
• Duke, B. O. L., Zea-Flores, G., Castro, J., Cupp, E. W. & Munoz, B. (1990). Effects of multiple monthly doses of ivermectin on adult Onchocerca volvulus. American Journal of Tropical Medicine and Hygiene, 43, 657-664.
   Google Scholar
• Duke, B. O. L., Zea-Flores, G., Castro, J., Cupp, E. W. & Munoz, B. (1992). Effects of three-month doses of ivermectin on adult Onchocerca volvulus. American Journal of Tropical Medicine and Hygiene, 46, 189-194.
   Google Scholar
• Gardon, J., Gardon-Wendel, N., Demanga-Ngangue, Kamgno, J., Chippaux, J. P. & Boussinesq, M. (1997). Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet, 350, 18-22.
   Google Scholar
• Gardon, J., Boussinesq, M., Kamgno, J., Gardon-Wendel, N., Demanga-Ngangue & Duke, B. O. L. (2002). Effects of standard and high doses of ivermectin on adult worms of Onchocerca volvulus: a randomized control trial. Lancet, 360, 203-210.
   Google Scholar
• Garms, R., Walsh, J. F. & Davies, J. B. (1979). Studies on the reinvasion of the Onchocerciasis Control Programme in the Volta River Basin by Simulium damnosum s.l. with emphasis on the south-western areas. Tropenmedizin und Parasitologie, 30, 345-362.
   Google Scholar
• Greene, B. M., Taylor, H. R., Cupp, E. W., Murphy, R. P., White, A. T., Aziz, M. A., Schulz-Key, H., D'Anna, S. A., Newland, H. S., Goldschmidt, L. P, Auer, C., Hanson, A. P., Freeman, S. V., Reber, E. W. & Williams, P. N. (1985). Comparison of ivermectin and diethylcarba-mazine in the treatment of onchocerciasis. New England Journal of Medicine, 313, 133-138.
   Google Scholar
• Hagan, M. (1998). Onchocercal dermatitis: clinical impact. Annals of Tropical Medicine and Parasitology, 92 (Suppl. 1), S85–S96.
   Google Scholar
• Hoerauf, A., Volkmann, L., Hammelmann, C., Adjei, O., Autenrieth, I. B., Fleischer, B. & Buttner, D. W. (2000). Endosymbiotic bacteria in worms as targets for a novel chemotherapy in filariasis. Lancet, 355,1242-1243.
   Google Scholar
• Hopkins, D. R., Richards, F. O. & Katabarwa, M. (2005). Whither onchocerciasis control in Africa? American Journal of Tropical Medicine and Hygiene, 72,1-2. Kale, O., Grunewald, J., Koulischer, G., Massougbodji, A. & Sachndeva, P. (2002). Onchocerciasis Control Programme External Evaluation. Ouagadougou: Onchocerciasis Control Programme.
   Google Scholar
• McMahon, J. P., Highlon, R. B. & Goiny, H. (1958). The eradication of Simulium naevei from Kenya. Bulletin of the World Health Organization, 18, 72-82. Molyneux, D. H. (1995). Onchocerciasis control in West Africa: current status and future of the onchocerciasis control programme. Parasitology Today, 11, 399-402.
   Google Scholar
• Molyneux, D. H. (2005). Onchocerciasis control and elimination: coming of age in resource-constrained health systems. Trends in Parasitology, 21, 525-529.
   Google Scholar
• Molyneux, D. H., Bradley, M., Hoerauf, A., Kyelem, D. & Taylor, M. J. (2003). Mass drug treatment for lymphatic filariasis and onchocerciasis. Trends in Parasitology, 19, 516–522.
   PubMed Web of Science ®Google Scholar
• Murdoch, M. E., Hay, R. J., Mackenzie, C. D., Williams, J. F., Ghalib, H. W., Cousens, S., Abiose, A. & Jones, B. R. (1993). A clinical classification and grading system of the cutaneous changes in onchocerciasis. British Journal of Dermatology, 129, 260–269.
   PubMed Web of Science ®Google Scholar
• Ngoumou, P. & Walsh, J. F. (1993). A Manual for Rapid Epidemiological Mapping of Onchocerciasis. Document TDR/TDE/ONCHO/93.4. Geneva: World Health Organization.
   Google Scholar
• Pfarr, K. M. & Hoerauf, A. M. (2006). Antibiotics which target the Wolbachia endosymbionts of filarial parasites: a new strategy for control of filariasis and amelioration of pathology. Mini Reviews in Medicinal Chemistry, 6, 203-210.
   Google Scholar
• Prost, A., Hervouet, J. P. & Thylefors, B. (1979). Les niveaux d'endemicité dans l'onchocercose. Bulletin of the World Health Organization, 57,655–662.
   PubMed Web of Science ®Google Scholar
• Remme, J., Baker, R. H. A., de Sole, G., Dadzie, K. Y., Walsh, J. F., Adams, M. A., Alley, E. S. & Avissey, H. S. (1989). A community trial of ivermectin in the onchocerciasis focus of Asubende, Ghana. I. Effect of the microfilarial reservoir and the transmis-sion of Onchocerca volvulus. Tropical Medicine and Parasitology, 40, 367–374.
   PubMedGoogle Scholar
• Richards F. O. Jr, Boatin, B., Sauerbrey, M. & Sékétéli, A. (2001). Control of onchocerciasis today: status and challenges. Trends in Parasitology, 17, 558-563.
   Google Scholar
• Sékétéli, A. (2002). APOC at mid-point: so far so good. Annals of Tropical Medicine and Parasitology, 96 (Suppl. 1), S3–S4.
   Google Scholar
• Taylor, H. R. & Greene, B. M. (1989). The status of ivermectin in the treatment of onchocerciasis. American Journal of Tropical Medicine and Hygiene, 41, 460-466.
   Google Scholar
• Taylor, H. R., Duke, B. O. L. & Munoz, B. (1992). The selection of communities for treatment of onchocerciasis with ivermectin. Tropical Medicine and Parasitology, 43, 267-270.
   Google Scholar
• Thylefors, B. (2004). Eliminating onchocerciasis as a public health problem. Tropical Medicine and International Health, 9 (Suppl.), A1–A3.
   Google Scholar
• Wanji, S., Tendongfor, N., Esum, M., Yundze, S. S. J., Taylor, M. J. & Enyong, P. (2005). Combined utilization of rapid assessment procedures for loiasis (RAPLOA) and onchocerciasis (REA) in rain forest villages of Cameroon. Filaria Journal, 4,2.
   PubMedGoogle Scholar
• Whitworth, J. A. G., Morgan, D., Maude, G. H., Luty, A. J. F. & Taylor, D. W. (1992). A community trial of ivermectin for onchocerciasis in Sierra Leone: clinical and parasitological responses to four doses given at six-month intervals. Transactions of the Royal Society of Tropical Medicine and Hygiene, 86, 277-280. Winnen, M., Plaisier, A. P., Alley, E. S., Nagelkerke, N. J., van Oortmarssen, G., Boatin, B. A. & Habbema, J. D. (2002). Can ivermectin mass treat-ments eliminate onchocerciasis in Africa? Bulletin of the World Health Organization, 80, 384-390.
   Google Scholar
• World Bank (1993). World Development Report: Investing in Health. New York, NY: Oxford University Press. World Health Organization (1976). Epidemiology of Onchocerciasis. Report of a WHO Expert Committee. Technical Report Series No. 591. Geneva: WHO. World Health Organization (1987). WHO Expert Committee on Onchocerciasis. Third Report. Technical Report Series No. 757. Geneva: WHO.
   Google Scholar
• World Health Organization (1995). Onchocerciasis and its Control. Report of a WHO Expert Committee. Technical Report Series No. 852. Geneva: WHO.
   Google Scholar
• World Health Organization (2001). Criteria for Certification of Interruption of Transmission/elimination of Human Onchocerciasis. Document WHO/CDS/ CPE/CEE/2001.18a. Geneva: WHO.
   Google Scholar
• World Health Organization (2002a). Success in Africa: the Onchocerciasis Control Programme in West Africa, 1974-2002. Technical Report Series No. 885. Geneva: WHO.
   Google Scholar
• World Health Organization (2002b). Onchocerciasis (river blindness). Weekly Epidemiology Record, 77, 249–256.
   PubMedGoogle Scholar
• World Health Organization (2005). Onchocerciasis (river blindness). Weekly Epidemiology Record, 80, 257–260.
   PubMedGoogle Scholar